Gil Schwartzberg - 30 Jun 2021 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director, 10%+ Owner
Signature
/s/ Gil Schwartzberg
Issuer symbol
LIXT
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jul 2021, 16:06:05 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Option to Purchase Common Stock Award $0 +100,000 $0.000000 100,000 30 Jun 2021 Common 100,000 $3.03 Direct F1
holding LIXT Option to Purchase Common Stock 250,000 30 Jun 2021 Common 250,000 $3.20 Direct F1
holding LIXT Warrant to Purchase Common Stock 105,264 30 Jun 2021 Common 105,264 $5.70 Direct
holding LIXT Options to Purchase Common Stock 291,667 30 Jun 2021 Common 291,667 $3.00 By Julie Schwartzberg Trust
holding LIXT Warrant to Purchase Common Stock 83,333 30 Jun 2021 Common 83,333 $6.00 By Julie Schwartzberg Trust
holding LIXT Warrant to Purchase Common Stock 83,333 30 Jun 2021 Common 83,333 $6.00 By David N. Sterling Trust
holding LIXT Options to Purchase Common Stock 83,333 30 Jun 2021 Common 83,333 $3.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021).